Shorter radiation vs standard for head and neck cancer
Part of Cancer clinical trials.
This trial compares two ways of giving radiation therapy for head and neck cancer to see if one works as well as the other while possibly being more convenient. You'll be randomly assigned to get either a shorter course of higher-dose radiation or the standard longer course, and the study will track your quality of life during and after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of a type of head and neck cancer (like in the mouth, throat, or voice box).
- You must be planning to receive treatment meant to cure the cancer, either surgery followed by radiation (with or without chemo) or radiation with chemo.
- Your cancer must not have spread to other organs.
- You should be generally well enough to carry out daily activities (some limitations are okay).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation therapy (hypofractionated radiotherapy) specifically for older adults with head and neck cancer that has not spread. The aim is to make treatment more convenient and manageable while still being effective, potentially with fewer side effects.
This trial compares two shortened radiation therapy schedules for patients with advanced head and neck cancer that cannot be cured. The goal is to see which schedule provides better symptom relief and quality of life with fewer side effects.
This trial compares two different radiation schedules after surgery for head and neck cancer. One schedule delivers radiation faster over fewer weeks, while the other uses the standard approach. The study tests whether the faster schedule works just as well while potentially reducing side effects.
This study tests a shorter course of radiation therapy (called hypofractionated radiotherapy) for people with head and neck cancer who have already had surgery to remove the tumor. It is for patients with certain 'intermediate-risk' features, aiming to improve outcomes while possibly reducing treatment time.
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
This trial tests a shorter course of radiation therapy for patients aged 65 and older with head and neck cancer who cannot have surgery or standard radiation. The goal is to find an effective and more convenient treatment option.
Hear when a new Radiation Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.